Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of July 21, 2026, VBIO trades at $0.35 with a market cap of $1.62M and a P/E ratio of 0.00. VBIO moved +1.08% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.35 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $1.62M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.21 |
| 52-Week Low | $0.35 |
| Volume | 220.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VBIO analyst coverage data. Average price target: $0.00.